Secondary Prevention of Coronary Heart Disease in Elderly Patients Following Myocardial Infarction: Are All HMG-CoA Reductase Inhibitors Alike?

By Maroo Bijesh P.   Lavie Carl J.   Milani Richard V.  

Drugs & Aging, Vol. 25, Iss. 8, 2008-01 ,pp. : 649-664

Adis International

Access to resources Recommend Favorite

Effects of HMG-CoA reductase inhibitors on excitation-contraction coupling of rat skeletal muscle

By Pierno S.   De Luca A.   Liantonio A.   Camerino C.   Conte Camerino D.  

European Journal of Pharmacology, Vol. 364, Iss. 1, 1999-01 ,pp. : 43-48

Elsevier

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors: Do They Have Potential in the Treatment of Polycystic Ovary Syndrome?

By Kodaman Pinar H.  

Drugs, Vol. 68, Iss. 13, 2008-01 ,pp. : 1771-1785

Adis International

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors in Osteoporosis: Do They Reduce the Risk of Fracture?

By Schlienger R.G.   Meier C.R.  

Drugs & Aging, Vol. 20, Iss. 5, 2003-01 ,pp. : 321-336

Adis International

Access to resources Recommend Favorite

Who Should Receive HMG CoA Reductase Inhibitors?

By Teo K.K.  

Drugs, Vol. 62, Iss. 12, 2002-01 ,pp. : 1707-1715

Adis International

Access to resources Recommend Favorite